Fyodor Urnov, PhD
Disclosures: NO DISCLOSURE




Fyodor Urnov both named and co-invented human (Nature 2005) and crop (Nature 2009) genome editing, and co-led the teams that initiated the first-in-human gene editing trials (for HIV), and the team that produced the world's first gene edited crops (low-phytate corn). He subsequently led the team from basic research to the first-ever open clinical trial for beta-thalassemia and sickle cell disease. Fyodor is a Professor in the Molecular and Cell Biology Department at the University of California, Berkeley, and the Scientific Director for Technology and Translation at the Innovative Genomics Institute where he works with Jennifer Doudna, who discovered the fundamental mechanism behind CRISPR-Cas9 and invented Cas9-driven genome editing. At the IGI, Fyodor leads a 4-year, $19.7 million effort funded by DARPA to develop a CRISPR-based countermeasure against radiation; he directs a $25 million Center for Translational Genomics at the IGI that aims to make crop trait engineering and human clinical trials with CRISPR turnkey; and is the Acting Director of the Laboratory for Genomics Research, a $67 million, 5 year partnership between the IGI and GSK that aims to use big data and genome editing to identify the next generation of targets to treat currently intractable disease.